Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Immunol ; 35(5): 1501-9, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15789355

RESUMO

Treatment (from 5 to 25 weeks of age) with a novel blocking monoclonal antibody, mAb I-10, directed against the plasma membrane (pm) form of LAMP-1, protected against development of autoimmune diabetes in the NOD mouse. A shorter course of treatment, i.e. from 5 to 12 weeks of age, significantly reduced the occurrence of insulitis as well as disease onset. Interfering with pm-LAMP-1 required continuous treatment as tolerance was not observed when treatment was stopped, and no higher proportion of cells with a T regulatory phenotype (e.g. CD4(+)CD25(+)) were induced. The mechanism appears to involve modulating a proinflammatory cytokine, as the proportion of pancreatic-infiltrating IFN-gamma-positive cells was significantly reduced in the mAb I-10-treated group. These results demonstrate an unexpected role for pm-LAMP-1 in autoimmune disease progression, and suggest that further investigation should be performed to understand how this molecule modulates IFN-gamma-driven responses.


Assuntos
Anticorpos Bloqueadores/imunologia , Anticorpos Monoclonais/imunologia , Antígenos CD/imunologia , Diabetes Mellitus Tipo 1/imunologia , Proteínas de Membrana/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Bloqueadores/farmacologia , Anticorpos Monoclonais/farmacologia , Western Blotting , Diabetes Mellitus Tipo 1/prevenção & controle , Modelos Animais de Doenças , Eletroforese em Gel de Poliacrilamida , Feminino , Citometria de Fluxo , Interferon gama/biossíntese , Interferon gama/efeitos dos fármacos , Interferon gama/imunologia , Proteínas de Membrana Lisossomal , Proteínas de Membrana/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos NOD , Dados de Sequência Molecular , Pâncreas/efeitos dos fármacos , Pâncreas/imunologia , Células Th1/efeitos dos fármacos , Células Th1/imunologia
2.
Biophys J ; 84(6): 3992-4010, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12770904

RESUMO

Fluorescence resonance energy transfer (FRET) is a technique used to measure the interaction between two molecules labeled with two different fluorophores (the donor and the acceptor) by the transfer of energy from the excited donor to the acceptor. In biological applications, this technique has become popular to qualitatively map protein-protein interactions, and in biophysical projects it is used as a quantitative measure for distances between a single donor and acceptor molecule. Numerous approaches can be found in the literature to quantify and map FRET, but the measures they provide are often difficult to interpret. We propose here a quantitative comparison of these methods by using a surface FRET system with controlled amounts of donor and acceptor fluorophores and controlled distances between them. We support the system with a Monte Carlo simulation of FRET, which provides reference values for the FRET efficiency under various experimental conditions. We validate a representative set of FRET efficiencies and indices calculated from the different methods with different experimental settings. Finally, we test their sensitivity and draw conclusions for the preparation of FRET experiments in more complex and less-controlled systems.


Assuntos
Algoritmos , Artefatos , Biotina/química , Transferência Ressonante de Energia de Fluorescência/métodos , Transferência Ressonante de Energia de Fluorescência/normas , Corantes Fluorescentes , Estreptavidina/química , Biotina/normas , Transferência Ressonante de Energia de Fluorescência/instrumentação , Método de Monte Carlo , Ligação Proteica , Controle de Qualidade , Padrões de Referência , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Estreptavidina/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA